90%Confidence
0Views
FDASource
2026-03-06Date
Summary
Asteria Health faces another testosterone recall for metal contamination, indicating potential systemic manufacturing issues across multiple product strengths. This pattern suggests deeper quality control problems requiring comprehensive remediation.
Actionable: Consider discontinuing use of Asteria Health testosterone products until manufacturing issues are resolved.
AI Confidence: 90%
Data Points
firmF.H. INVESTMENTS, Inc. (dba Asteria Health)
classificationClass II
statusOngoing
distributionNationwide in the USA
productTestosterone, 200 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1200-43.
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now